Physician profile
Keisha Sullivan
NPI 1437545720
$1,563.87
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $185 · 2020: $11.10 · 2021: $110 · 2022: $1,235 · 2023: $23.09.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $23.09.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $23.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Respicardia, INC. | $575.05 | 2022 | |
| Jazz Pharmaceuticals INC. | $414.25 | 2019-2022 | |
| Resmed Corp | $266.68 | 2019-2022 | |
| Inspire Medical Systems, INC. | $132.86 | 2022 | |
| Harmony Biosciences LLC | $44.66 | 2022 | |
| Eisai INC. | $32.11 | 2021 | |
| Abbvie INC. | $24.06 | 2019 | |
| Paratek Pharmaceuticals, INC. | $23.97 | 2021 | |
| Idorsia Pharmaceuticals US INC | $23.09 | 2023 | Quviviq |
| Portola Pharmaceuticals, LLC | $15.75 | 2019 | |
| Mylan Specialty L.P. | $11.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keisha Sullivan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.